Circ-EIF6, encoding the novel peptide EIF6-224aa, enhances proliferation and metastasis of triple-negative breast cancer cells by activating the MYH9/Wnt/β-catenin pathway [26]. This evidence concerns the gene MYH9 and triple-negative breast carcinoma.